Business Market Insights

The  Medical Aesthetics Market in North America  is expected to grow from US$ 2,512.24 million in 2021 to US$ 5,823.87 million by 2028; it is estimated to grow at a CAGR of 12.8% from 2021 to 2028. Technological advancements associated with medical aesthetic devices; all medical devices used for various cosmetic procedures, including plastic surgery, unwanted hair removal, excess fat removal, anti-aging, aesthetic implants, skin tightening, etc., are categorized under the medical aesthetic products umbrella. Technological advancements in devices, increasing awareness about aesthetic procedures, growing acceptance of minimally invasive devices, and surge in obese population are the main forces boosting the medical aesthetics market growth. The List of Companies - North America Medical Aesthetics Market Allergan Plc Alma Lasers Cutera Inc Galderma Hologic, Inc. Mentor Worldwide, LLC Sientra Solta Medical Download Sample PDF Copy:  https://www.businessmarketinsights.com...

The   Stevia Market in North America   is expected to grow from US$ 122.83 million in 2021 to US$ 212.38 million by 2028; it is estimated to grow at a CAGR of 8.1% from 2021 to 2028.  The List of Companies  Cargill, Incorporated Ingredion Incorporated Tate & Lyle PLC GLG Life Tech Corp The Archer-Daniels-Midland Company S&W Seed Company Morita Kagaku Kogyo Co., Ltd. PureCircle Several domestic and international companies have a strong foothold in the North American region. These companies are constantly working towards innovation and new product developments of stevia with improved tastes and qualities to attract new consumers and widen the consumer base in the region. North America Stevia Market Segmentation North America Stevia Market -By Type Whole Leaf Powder Liquid North America Stevia Market -By Application Dairy and Frozen Dessert Bakery and Confectionery Tabletop Sweetener Beverages Others North America Stevia Market – By Country US Canada Mexico Nort...

The  long read sequencing market in North America  is expected to grow from US$ 570.24 million in 2021 to US$ 2,254.97 million by 2028; it is estimated to grow at a CAGR of 21.7% from 2021 to 2028.  Five years ago, genomic sequencing was restricted to the research environment. At present, it is increasingly used in clinical practice, and over the next five years, genomic data from over 60 million patients are expected to be generated within healthcare. Genomic sequencing is rapidly transitioning into clinical practice, and implementation into healthcare systems has been supported by substantial government investment, totaling over US$ 4 billion in at least 14 countries. These national genomic-medicine initiatives drive transformative change under real-life conditions while addressing barriers to implementation and gathering evidence for broader adoption, thereby driving the market growth. The List of Companies  Bionano Genomics F. HOFFMANN-LA ROCHE LTD. Illumina, Inc...

The   artificial intelligence market in North America , is expected to reach US$ 35,863.11 million by 2028 from US$ 5,192.21 million in 2021. The market is estimated to grow at a CAGR of 31.8% from 2021 to 2028. Cloud computing is reducing the entry barrier for smaller companies seeking to profit from compute-intensive business analytics that was previously only open to the large corporations. Smaller companies are increasingly gaining access to AI. These cloud-based AI solutions effectively allow and enhance the adoption of AI. Cloud-based applications and services can provide users with immediate access to hardware services with no upfront capital investments, resulting in a faster time to market in many industries. Hence, the cloud has become an adaptable infrastructure that can be shared by different end users who may use it in a variety of ways. The List of Companies  Accenture Adobe Affectiva Amazon Web Services Bidalgo CognitiveScale IBM Corporation Microsoft Corporatio...

According to a new market research study of “ North America Multiple Sclerosis Therapeutics Market   Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class, Route of Administration, Distribution Channel and Country.” The North America multiple sclerosis therapeutics market is expected to reach US$ 15,269.74 million by 2027 from US$ 9,144.98 million in 2019; it is estimated to grow at a CAGR of 6.8% from 2020 to 2027. The report highlights trends prevailing in the North America multiple sclerosis therapeutics market and the factors driving market along with those that act as hindrances. The List of Companies  Merck & Co., Inc. Novartis AG Bayer AG Sanofi Bristol-Myers Squibb Company Horizon Therapeutics plc TEVA PHARMACEUTICAL INDUSTRIES LTD Takeda Pharmaceutical Company Limited F. HOFFMANN-LA ROCHE LTD Biogen Download Sample PDF Copy:  https://www.businessmarketinsights.com/sample/TIPRE00022633 By Drug Class Immunosuppressant Immunomodulators By Route ...

The   Artificial intelligence in healthcare market in North America   is expected to grow from US$ 1,605.67 million in 2019 to US$ 44,056.97 million by 2027; it is estimated to grow at a CAGR of 50.1% from 2020 to 2027. Cross-industry partnerships are resulting into the introduction of new machine learning models that predict risk and provide cognitive assistance. AI is mostly applied in the clinical trials to obtain accurate and valuable output. For instance, the AI-based tools, such as clinical decision support systems and voice recognition software, help streamline workflow processes in hospitals and improve medical care, thereby enhancing the patient experience. Cross-sector partnerships are among the most dynamic practice within corporate and society relations that bridge various sectors, such as public, private, and nonprofit.  Therefore, the rising number of cross-industry partnerships is projected to improve AI adoption in the healthcare sector, which propels the ...

The   batter and breader premixes market in North America   was valued at US$ 726.74 million in 2019 and is projected to reach US$ 1,149.04 million by 2027; it is expected to grow at a CAGR of 6.2% from 2020 to 2027. The key factor driving the  batter and breader premixes market growth is the increasing inclination of the populace toward convenience foods, including processed meat and seafood. Rising health-related awareness preference for convenience food items among the North American population has mainly led to the rising demands for product like batter and breader premixes in this region. Download Sample PDF Copy:  https://www.businessmarketinsights.com/sample/TIPRE00019175 Market Overview Batter and breader premixes are essential food coatings used to enhance the flavor, texture, and moisture retention of meat, poultry, seafood, fish, and vegetables during frying or grilling. Batter is a thin, flour-based mixture combined with liquids such as water, milk, or eg...